{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:27:38Z","timestamp":1793291258918,"version":"4.5.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.2967\/jnumed.118.212233","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T19:04:45Z","timestamp":1532459085000},"page":"362-368","source":"Crossref","is-referenced-by-count":309,"title":["Detection Efficacy of <sup>18<\/sup>F-PSMA-1007 PET\/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy"],"prefix":"10.2967","volume":"60","author":[{"given":"Frederik L.","family":"Giesel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Will","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Flechsig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasko","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"2021051712130236000_60.3.362.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-009-1647-4"},{"key":"2021051712130236000_60.3.362.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2949-6"},{"key":"2021051712130236000_60.3.362.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154153"},{"key":"2021051712130236000_60.3.362.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.12.025"},{"key":"2021051712130236000_60.3.362.5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol."},{"key":"2021051712130236000_60.3.362.6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130236000_60.3.362.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160382"},{"key":"2021051712130236000_60.3.362.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2069-0"},{"key":"2021051712130236000_60.3.362.9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2018.01.006","article-title":"Efficacy, predictive factors, and prediction nomograms for 68Ga-labeled prostate-specific membrane antigen\u2013ligand positron-emission tomography\/computed tomography in early biochemical recurrent prostate cancer after radical prostatectomy","volume":"73","author":"Rauscher","year":"2018","journal-title":"Eur Urol."},{"key":"2021051712130236000_60.3.362.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.104661"},{"key":"2021051712130236000_60.3.362.11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130236000_60.3.362.12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"Eiber","year":"2016","journal-title":"Eur Urol."},{"key":"2021051712130236000_60.3.362.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2660-z"},{"key":"2021051712130236000_60.3.362.14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","article-title":"Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI","volume":"44","author":"Freitag","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130236000_60.3.362.15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph10040077","article-title":"Procedures for the GMP-compliant production and quality control of [18F]PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer","volume":"10","author":"Cardinale","year":"2017","journal-title":"Pharmaceuticals (Basel)."},{"key":"2021051712130236000_60.3.362.16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics."},{"key":"2021051712130236000_60.3.362.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3106-6"},{"key":"2021051712130236000_60.3.362.18","doi-asserted-by":"crossref","first-page":"482.e5","DOI":"10.1016\/j.urolonc.2016.05.026","article-title":"Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng\/ml following prostatectomy: how much information can conventional imaging provide?","volume":"34","author":"Vargas","year":"2016","journal-title":"Urol Oncol."},{"key":"2021051712130236000_60.3.362.19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2352040494"},{"key":"2021051712130236000_60.3.362.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-008-0263-8"},{"key":"2021051712130236000_60.3.362.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-012-1354-4"},{"key":"2021051712130236000_60.3.362.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0150-2"},{"key":"2021051712130236000_60.3.362.23","first-page":"549","article-title":"11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse","volume":"44","author":"Oyama","year":"2003","journal-title":"J Nucl Med."},{"key":"2021051712130236000_60.3.362.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2012.06.034"},{"key":"2021051712130236000_60.3.362.25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cpet.2017.02.006","article-title":"Imaging of prostate-specific membrane antigen using [18F]DCFPyL","volume":"12","author":"Rowe","year":"2017","journal-title":"PET Clin."},{"key":"2021051712130236000_60.3.362.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.196329"},{"key":"2021051712130236000_60.3.362.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.196683"},{"key":"2021051712130236000_60.3.362.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3188-1"},{"key":"2021051712130236000_60.3.362.29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.117.204669","article-title":"Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET\/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study","volume":"59","author":"Giesel","year":"2018","journal-title":"J Nucl Med."},{"key":"2021051712130236000_60.3.362.30","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00259-018-3952-0","article-title":"Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion","volume":"45","author":"Rahbar","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130236000_60.3.362.31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40644-017-0132-6","article-title":"Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET\/CT in prostate cancer patients","volume":"17","author":"Will","year":"2017","journal-title":"Cancer Imaging."},{"key":"2021051712130236000_60.3.362.32","doi-asserted-by":"crossref","first-page":"540\u2013545","DOI":"10.1016\/j.juro.2006.10.097","article-title":"Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.212233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:34:47Z","timestamp":1621283687000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.212233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,1]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.2967\/jnumed.118.212233"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.212233","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]}}}